{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T01:32:48Z","timestamp":1772155968647,"version":"3.50.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1097\/dad.0b013e31827b9450","type":"journal-article","created":{"date-parts":[[2013,11,18]],"date-time":"2013-11-18T14:12:05Z","timestamp":1384783925000},"page":"833-841","source":"Crossref","is-referenced-by-count":19,"title":["CD20+ Mycosis Fungoides"],"prefix":"10.1097","volume":"35","author":[{"given":"Jo.shua W.","family":"Hagen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen T.","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia M.","family":"Magro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-9-20210202","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":". WHO-EORTC classification for cutaneous lymphomas.","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"R2-9-20210202","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(08)60420-1","article-title":". Mycosis fungoides and Sezary syndrome.","volume":"371","author":"Hwang","year":"2008","journal-title":"Lancet"},{"key":"R3-9-20210202","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1182\/blood.V70.5.1316.1316","article-title":". Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development.","volume":"70","author":"Loken","year":"1987","journal-title":"Blood"},{"key":"R4-9-20210202","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/modpathol.3880133","article-title":". Immunoreactivity of B-cell markers (CD79a, L26) in rare cases of extranodal cytotoxic peripheral T- (NKT-) cell lymphomas.","volume":"13","author":"Blakolmer","year":"2000","journal-title":"Mod Pathol"},{"key":"R5-9-20210202","first-page":"263","article-title":". CD20 positive T-cell lymphomaleukemia: a rare entity with potential diagnostic pitfalls.","volume":"37","author":"Buckner","year":"2007","journal-title":"Ann Clin Lab Sci"},{"key":"R6-9-20210202","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1309\/HPYGFLNXKFBHDQEV","article-title":". Primary CD20CD10CD8 T-cell lymphoma of the skin with IgH and TCR beta gene rearrangement.","volume":"126","author":"Magro","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"R7-9-20210202","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/modpathol.3880229","article-title":"CD20-positive peripheral T-cell lymphoma: report of a case after nodular sclerosis Hodgkins disease and review of the literature.","volume":"13","author":"Mohrmann","year":"2000","journal-title":"Mod Pathol"},{"key":"R8-9-20210202","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/ajcp\/102.4.483","article-title":". CD20 T-cell lymphoma. Neoplastic transformation of a normal T-cell subset.","volume":"102","author":"Quintanilla-Martinez","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"R9-9-20210202","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/path.1711520202","article-title":". T-cell lymphomas in adults: a clinicopathological study of eighteen cases.","volume":"152","author":"Ramsay","year":"1987","journal-title":"J Pathol"},{"key":"R10-9-20210202","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1600-0560.2007.00817.x","article-title":". CD20 positive mycosis fungoides: a case report.","volume":"35","author":"Sen","year":"2008","journal-title":"J Cutan Pathol"},{"key":"R12-9-20210202","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1046\/j.1365-2141.1998.00884.x","article-title":". CD20-positive T-cell chronic lymphocytic leukaemia.","volume":"102","author":"Takami","year":"1998","journal-title":"Br J Haematol"},{"key":"R13-9-20210202","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/ajh.10224","article-title":". CD3-negative, CD20-positive T-cell prolymphocytic leukemia: case report and review of the literature.","volume":"1","author":"Tamayose","year":"2002","journal-title":"Am J Hematol"},{"key":"R14-9-20210202","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3960\/jslrt.45.45","article-title":"CD20-positive cytotoxic T cell lymphoma: report of two cases and review of the literature.","volume":"45","author":"Kitamura","year":"2005","journal-title":"J Clin Exp Hematop"},{"key":"R15-9-20210202","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/modpathol.3880265","article-title":". Peripheral T-cell lymphoma with aberrant expression of CD79a and CD20: a diagnostic pitfall.","volume":"14","author":"Yao","year":"2001","journal-title":"Mod Pathol"},{"key":"R16-9-20210202","first-page":"798","article-title":". CD20dim-positive T-cell large granular lymphocytic leukemia in a patient with concurrent hairy cell leukemia and plasma cell myeloma.","volume":"3","author":"Xu","year":"2010","journal-title":"Int J Clin Exp Pathol"},{"key":"R17-9-20210202","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s002770100297","article-title":". CD20-positive T cell leukemialymphoma: case report and review of the literature.","volume":"80","author":"Yokose","year":"2001","journal-title":"Ann Hematol"},{"key":"R18-9-20210202","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/DAD.0b013e31818cc039","article-title":". Primary cutaneous peripheral T-cell lymphoma with aberrant coexpression of CD20: case report and review of the literature.","volume":"31","author":"Balmer","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"R19-9-20210202","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/cyto.990140212","article-title":". CD20 (pan-B cell) antigen is expressed at a low level on a subpopulation of human T-lymphocytes.","volume":"14","author":"Hultin","year":"1993","journal-title":"Cytometry"},{"key":"R20-9-20210202","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1097\/PAS.0b013e31817d7452","article-title":". CD20 T-cell lymphoma: clinicopathologic analysis of 9 cases and a review of the literature.","volume":"32","author":"Rahemtullah","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R21-9-20210202","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":". Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"R22-9-20210202","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/sj.leu.2404479","article-title":"Pott Ch, Groenen PJ, et al.. Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936.","volume":"21","author":"Evans","year":"2007","journal-title":"Leukemia"},{"key":"R23-9-20210202","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1468-3083.2011.04383.x","article-title":". Childhood mycosis fungoides: a report of 20 cases from Turkey.","volume":"27","author":"Yazganoglu","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R24-9-20210202","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/ajcp\/106.1.78","article-title":". CD20 (pan-B cell antigen) expression on bone marrow-derived T cells.","volume":"106","author":"Algino","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"R25-9-20210202","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/cyto.990180206","article-title":". Low level CD20 expression on T cell malignancies.","volume":"18","author":"Warzynski","year":"1994","journal-title":"Cytometry"},{"key":"R26-9-20210202","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1182\/blood-2008-06-164129","article-title":". CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy.","volume":"112","author":"Dworzak","year":"2008","journal-title":"Blood"},{"key":"R27-9-20210202","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood.V100.5.1765.h81702001765_1765_1773","article-title":"Glucocorticoids and rituximab in vitro: synergistic direct antiproliferative and apoptotic effects.","volume":"100","author":"Rose","year":"2002","journal-title":"Blood"},{"key":"R28-9-20210202","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ijc.25657","article-title":". Synergistic activation by p38MAPK and glucocorticoid signaling mediates induction of M2-like tumor-associated macrophages expressing the novel CD20 homolog MS4A8A.","volume":"129","author":"Schmieder","year":"2011","journal-title":"Int J Cancer"},{"key":"R29-9-20210202","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1083\/jcb.121.5.1121","article-title":". Transfection of the CD20 cell surface molecule into ectopic cell types generates a Ca2 conductance found constitutively in B lymphocytes.","volume":"121","author":"Bubien","year":"1993","journal-title":"J Cell Biol"},{"key":"R30-9-20210202","doi-asserted-by":"crossref","first-page":"13099","DOI":"10.1074\/jbc.270.22.13099","article-title":". Expression of calcium-permeable cation channel CD20 accelerates progression through the G1 phase in Balbc 3T3 cells.","volume":"270","author":"Kanzaki","year":"1995","journal-title":"J Biol Chem"},{"key":"R31-9-20210202","doi-asserted-by":"crossref","first-page":"e13780","DOI":"10.1371\/journal.pone.0013780","article-title":". MS4a4B, a CD20 homologue in T cells, inhibits T cell propagation by modulation of cell cycle.","volume":"5","author":"Xu","year":"2010","journal-title":"PLoS One"},{"key":"R32-9-20210202","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/path.2620","article-title":". PAX5 activates the transcription of the human telomerase reverse transcriptase gene in B cells.","volume":"220","author":"Bougel","year":"2010","journal-title":"J Pathol"},{"key":"R33-9-20210202","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1440-1827.2011.02784.x","article-title":". Primary cutaneous CD30 positive T-cell lymphoproliferative disorders with aberrant expression of PAX5: report of three cases.","volume":"62","author":"Hagiwara","year":"2012","journal-title":"Pathol Int"},{"key":"R34-9-20210202","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.coi.2008.05.011","article-title":"Immunotherapeutic mechanisms of anti-CD20 monoclonal antibodies.","volume":"20","author":"Taylor","year":"2008","journal-title":"Curr Opin Immunol"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0b013e31827b9450","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T13:22:31Z","timestamp":1716124951000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000372-201312000-00009"}},"subtitle":["A Report of Three Cases and Review of the Literature"],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0b013e31827b9450","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718182131.793488365","asserted-by":"object"}]},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}